

Cover Story
COVID-19 & CancerFreeGuest Editorial
Cancer patients and survivors should not get COVID-19. A three-time cancer survivor should definitely not get COVID. But I did. And it was not good. Here is my story and the lessons I learned that might be of value to others.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for Jan. 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care













